584 Appendices 543. Kushchayeva Y, Duh QY, Kebebew E, D’Avanzo A, Clark OH. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. Am J Surg. 2008;195:457-462. https:// doi.org/10.1016/j.amjsurg.2007.06.001. 544. Oluic B, Paunovic I, Loncar Z, Djukic V, Diklic A, Jovanovic M, et al. Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience. BMC cancer. 2017;17:371. https://doi.org/10.1186/s12885-017-3370-x. 545. Castagna MG, Maino F, Cipri C, Belardini V, Theodoropoulou A, Cevenini G, et al. Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. European journal of endocrinology. 2011;165:441-446. https://doi.org/10.1530/EJE-11-0466. 546. Pitoia F, Jerkovich F, Urciuoli C, Schmidt A, Abelleira E, Bueno F, et al. Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence. Thyroid. 2015;25:1235-1242. https://doi.org/10.1089/thy.2015.0121. 547. Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;20:1341-1349. https://doi.org/10.1089/thy.2010.0178. 548. Vaisman F, Momesso D, Bulzico DA, Pessoa CH, Dias F, Corbo R, et al. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clinical endocrinology. 2012;77:132-138. https:// doi.org/10.1111/j.1365-2265.2012.04342.x. 549. Goffredo P, Cheung K, Roman SA, Sosa JA. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Annals of surgical oncology. 2013;20:767-772. https://doi.org/10.1245/s10434-012-2697-4. 550. Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Annals of surgery. 2014;260:601-605; discussion 605-607. https://doi.org/10.1097/SLA.0000000000000925. 551. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer. 2000;89:202-217. https://doi.org/10.1002/1097-0142(20000701)89:1<202::aid-cncr27>3.0.co;2-a. 552. Bergenfelz A, Jansson S, Kristoffersson A, Martensson H, Reihner E, Wallin G, et al. Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbeck’s archives of surgery. 2008;393:667-673. https://doi.org/10.1007/s00423-008-0366-7. 553. Elfenbein DM, Schneider DF, Chen H, Sippel RS. Surgical site infection after thyroidectomy: a rare but significant complication. The Journal of surgical research. 2014;190:170-176. https://doi.org/10.1016/j.jss.2014.03.033. 554. Sheahan P, O’Connor A, Murphy MS. Comparison of incidence of postoperative seroma between flapless and conventional techniques for thyroidectomy: a case-control study. Clinical otolaryngology. 2012;37:130-135. https:// doi.org/10.1111/j.1749-4486.2012.02454.x. 555. Sanabria A, Carvalho AL, Silver CE, Rinaldo A, Shaha AR, Kowalski LP, et al. Routine drainage after thyroid surgery--a meta-analysis. Journal of surgical oncology. 2007;96:273-280. https://doi.org/10.1002/jso.20821. 556. Loyo M, Tufano RP, Gourin CG. National trends in thyroid surgery and the effect of volume on short-term outcomes. The Laryngoscope. 2013;123:2056-2063. https://doi.org/10.1002/lary.23923. 557. Lee YS, Nam KH, Chung WY, Chang HS, Park CS. Postoperative complications of thyroid cancer in a single center experience. Journal of Korean medical science. 2010;25:541-545. https://doi.org/10.3346/jkms.2010.25.4.541. 558. Zanocco KA, Wang MM, Yeh MW, Livhits MJ. Selective use of Molecular Testing Based on Sonographic Features of Cytologically Indeterminate Thyroid Nodules: A Decision Analysis. World journal of surgery. 2019:393–401. https:// doi.org/10.1007/s00268-019-05177-7. 559. Verloop H, Louwerens M, Schoones JW, Kievit J, Smit JW, Dekkers OM. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. The Journal of clinical endocrinology and metabolism. 2012;97:2243-2255. https://doi.org/10.1210/jc.2012-1063. 560. D’Orazi V, Sacconi A, Trombetta S, Karpathiotakis M, Pichelli D, Di Lorenzo E, et al. May predictors of difficulty in thyroid surgery increase the incidence of complications? Prospective study with the proposal of a preoperative score. BMC surgery. 2019;18:116. https://doi.org/10.1186/s12893-018-0447-7. 561. Ramouz A, Rasihashemi SZ, Daghigh F, Faraji E, Rouhani S. Predisposing factors for seroma formation in patients undergoing thyroidectomy: Cross-sectional study. Ann Med Surg. 2017;23:8-12. https://doi.org/10.1016/j. amsu.2017.09.001. 562. Zanocco K, Heller M, Elaraj D, Sturgeon C. Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options. Surgery. 2012;152:164-172. https://doi. org/10.1016/j.surg.2012.02.020.
RkJQdWJsaXNoZXIy MTk4NDMw